Med-chemist - med-chemist.com - Med-Chemist
General Information:
Latest News:
Combined therapy could repair and prevent damage in Duchenne muscular dystrophy, study suggests 27 Aug 2013 | 06:27 am
Results from a clinical trial of eteplirsen, {RNA, [P-deoxy-P-(dimethylamino)](2',3'-dideoxy-2',3'-imino-2',3'-seco)(2'a→5')(C-m5U- C-C-A-A-C-A-m5U-C-A-A-G-G-A-A-G-A-m5U-G-G-C-A-m5U-m5U-m5U-C-m5U-A-...
New approach in the treatment of breast cancer 26 Aug 2013 | 06:12 am
Scientists at the MedUni Vienna, in collaboration with a working group led by Nancy Hynes at the University of Basel, have discovered a new approach in the treatment of breast cancer: an international...
GLENMARK-A new way for a new world « New Drug Approvals 25 Aug 2013 | 01:41 pm
Undiminished zest.. “Every year we expect two more molecules to get into clinical trials,” says Saldanha, his zest undiminished by past failures. “In 2008, in a span of one or two quarters, our entir...
New treatment for brittle bone disease found 23 Aug 2013 | 06:08 am
We know that, Risedronic acid (see structure) (INN) or risedronate sodium (USAN) is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone. It is pr...
New role for Tamoxifen in saving high-risk breast cancer patients 22 Aug 2013 | 05:51 am
In continuation of my update on Tamoxifen... New role for Tamoxifen in saving high-risk breast cancer patients Ref : http://jco.ascopubs.org/content/early/2013/08/05/JCO.2012.47.8313 Medicinal Chem...
New designer compound JQ1, treats heart failure by targeting cell nucleus 21 Aug 2013 | 06:05 am
Researchers from Case Western Reserve University School of Medicine and the Dana-Farber Cancer Institute have made a fundamental discovery relevant to the understanding and treatment of heart failure ...
Scripps Florida Scientists Devise New Way to Dramatically Raise RNA Treatment Potency 21 Aug 2013 | 05:49 am
"We're trying to make tools that can target any RNA motif," said Matthew Disney, a TSRI associate professor who authored the research with a research associate in his lab, Lirui Guan. "This study comp...
Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases 20 Aug 2013 | 05:38 am
The UCLA researchers, led by David Eisenberg, director of the UCLA-Department of Energy Institute of Genomics and Proteomics and a Howard Hughes Medical Institute investigator, report the first applic...
GlaxoSmithKline receives CHMP positive opinion for REVOLADE 19 Aug 2013 | 05:46 am
In continuation of my update on Eltrombopag Eltrombopag (codenamed SB-497115-GR) is a medication that has been developed for conditions that lead to thrombocytopenia (abnormally low platelet counts)....
Rapamycin: Limited anti-aging effects 16 Aug 2013 | 06:01 am
In continuation of my update on Rapamycin The drug rapamycin is known to increase lifespan in mice. Whether rapamycin slows down aging, however, remains unclear. A team of researchers from the German...
